<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>On The Wards &#187; Addiction</title>
	<atom:link href="http://onthewards.com/category/articles/addiction/feed/" rel="self" type="application/rss+xml" />
	<link>http://onthewards.com</link>
	<description>Medical blog</description>
	<lastBuildDate>Sat, 17 Jul 2010 18:50:06 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>New &amp; Interesting (21 June 2010)</title>
		<link>http://onthewards.com/2010/06/new-interesting-21-june-2010/</link>
		<comments>http://onthewards.com/2010/06/new-interesting-21-june-2010/#comments</comments>
		<pubDate>Mon, 21 Jun 2010 19:03:01 +0000</pubDate>
		<dc:creator>wardslave</dc:creator>
				<category><![CDATA[Addiction]]></category>
		<category><![CDATA[Allergy & Immunology]]></category>
		<category><![CDATA[Hepatology]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Nutrition]]></category>
		<category><![CDATA[Pharmacology]]></category>
		<category><![CDATA[Rheumatology]]></category>

		<guid isPermaLink="false">http://onthewards.com/?p=638</guid>
		<description><![CDATA[The &#8220;New &#038; Interesting&#8221; series is a biweekly compilation of select research findings, news articles, and random tidbits in bullet-point format. The entries are highly abbreviated, but provide links to the original articles or abstracts if you desire to read further.
General Articles

Telaprevir leads to 75% cure rate in hepatitis C virus (HCV) infected individuals, as [...]]]></description>
		<wfw:commentRss>http://onthewards.com/2010/06/new-interesting-21-june-2010/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>New &amp; Interesting (7 June 2010)</title>
		<link>http://onthewards.com/2010/06/new-interesting-7-june-2010/</link>
		<comments>http://onthewards.com/2010/06/new-interesting-7-june-2010/#comments</comments>
		<pubDate>Mon, 07 Jun 2010 15:00:02 +0000</pubDate>
		<dc:creator>wardslave</dc:creator>
				<category><![CDATA[Addiction]]></category>
		<category><![CDATA[Allergy & Immunology]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Hepatology]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Nutrition]]></category>
		<category><![CDATA[Pharmacology]]></category>

		<guid isPermaLink="false">http://onthewards.com/?p=611</guid>
		<description><![CDATA[The &#8220;New &#038; Interesting&#8221; series is a biweekly compilation of select research findings, news articles, and random tidbits in bullet-point format. The entries are highly abbreviated, but provide links to the original articles or abstracts if you desire to read further.
General Articles

Telaprevir leads to 75% cure rate in hepatitis C virus (HCV) infected individuals, as [...]]]></description>
		<wfw:commentRss>http://onthewards.com/2010/06/new-interesting-7-june-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New &amp; Interesting (13 July 2009)</title>
		<link>http://onthewards.com/2009/07/new-interesting-13-july-2009/</link>
		<comments>http://onthewards.com/2009/07/new-interesting-13-july-2009/#comments</comments>
		<pubDate>Mon, 13 Jul 2009 22:40:00 +0000</pubDate>
		<dc:creator>wardslave</dc:creator>
				<category><![CDATA[Addiction]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Nephrology]]></category>
		<category><![CDATA[Neurology]]></category>
		<category><![CDATA[Nutrition]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Urology]]></category>

		<guid isPermaLink="false">http://onthewards.com/?p=377</guid>
		<description><![CDATA[The &#8220;New &#038; Interesting&#8221; series is a biweekly compilation of select research findings, news articles, and random tidbits in bullet-point format. The entries are highly abbreviated, but provide links to the original articles or abstracts if you desire to read further.
General Interest Articles

Caffeine may lower Alzheimer&#8217;s risk … in mice. More studies are however necessary [...]]]></description>
		<wfw:commentRss>http://onthewards.com/2009/07/new-interesting-13-july-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Advisory on Chantix</title>
		<link>http://onthewards.com/2008/02/fda-advisory-on-chantix/</link>
		<comments>http://onthewards.com/2008/02/fda-advisory-on-chantix/#comments</comments>
		<pubDate>Wed, 06 Feb 2008 05:12:02 +0000</pubDate>
		<dc:creator>wardslave</dc:creator>
				<category><![CDATA[Addiction]]></category>
		<category><![CDATA[Consumer Health]]></category>
		<category><![CDATA[Pharmacology]]></category>
		<category><![CDATA[Psychiatry]]></category>
		<category><![CDATA[Chantix]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[varenicline]]></category>

		<guid isPermaLink="false">http://onthewards.com/2008/02/05/fda-advisory-on-chantix/</guid>
		<description><![CDATA[The FDA (Food and Drug Administration) recently released a public health advisory on Chantix (varenicline), a smoking cessation drug manufactured by Pfizer. This follows an earlier investigation last year on reported behavioral changes associated with use of the drug. The presence of neurologic or psychiatric effects is not completely surprising, considering that Chantix interferes with [...]]]></description>
		<wfw:commentRss>http://onthewards.com/2008/02/fda-advisory-on-chantix/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
